Welcome to episode 049 of Life Sciences 360.In this episode of Life Sciences 360, host Harsh Thakkar welcomes Jesse Mendelsohn, Senior Vice President at Model N. Jesse delves into the intricacies of revenue optimization and compliance within the pharmaceutical industry. He shares insights on how Model N's platform aids pharmaceutical companies in navigating complex pricing, regulatory challenges, and government negotiations.Chapters :0:00 - Introduction1:30 - Welcoming Jesse Mendelsohn2:00 - Jesse's Journey with Model N6:00 - Evolution of Pharma Pricing and Compliance8:30 - Challenges in Commercial Contracting12:00 - Regulatory Side of Pharma Pricing14:30 - Impact of Government as a Major Drug Purchaser16:00 - Inflation Reduction Act Overview19:00 - Medicare's Right to Negotiate Drug Prices21:00 - Aftershocks of the Inflation Reduction Act23:30 - Key Takeaways for Pharma Executives26:00 - Impact on Drug Development Strategy28:00 - Generics and Biosimilars Market Impact30:30 - Positive Outcomes of the Inflation Reduction Act32:00 - What's Next for Model N36:00 - Importance of Accurate Data in Pricing38:30 - Closing Remarks and Connect with Jesse----- Links:* Jesse Mendelsohn LinkedIn (https://www.linkedin.com/in/jessedm/)* Model N LinkedIn (https://www.linkedin.com/company/modeln/)* Model N website (https://www.modeln.com/)*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/  )*Listen to this episode on the go! 🍎Apple podcast: https://apple.co/3RXPoS1🟩 Spotify podcast: https://spoti.fi/3EbDZbr👍 Like this video if you enjoy diving deep into the latest healthcare trends.For transcripts, check out the podcast website - www.lifesciencespod.com

Ver todos los episodios